Neuronal injury may be dependent upon the gen eration of the free radical nitric oxide (NO) and the subsequent induction of programed cell death (PCD). Although the nature of this injury may be both preventable and reversible, the un derlying mechanisms that mediate PCD are not well under stood. Using the agent nicotinamide as an investigative tool in primary rat hippocampal neurons, the authors examined the ability to modulate two independent components of PCD, namely the degradation of genomic DNA and the early expo sure of membrane phosphatidylserine (PS) residues. Neuronal injury was determined through trypan blue dye exclusion, DNA fragmentation, extemalization of membrane PS residues, cys teine protease activation, and the measurement of intracellular pH (pHJ Exposure to the NO donors SIN-I and NOC-9 (300 f,LmoIlL) alone rapidly increased genomic DNA fragmentation from 20 ± 4% to 71 ± 5% and membrane PS exposure from 14 ± 3% to 76 ± 9% over a 24-hour period. Administration of a
the subsequent discharge of toxic products to neighbor ing cells. Programmed cell death without effective modulation may precipitate neurodegenerative diseases, such as Alzheimer' s disease, Huntington' s disease, and Parkinson' s disease (Thomas et aI., 1995) . Although the mechanisms that result in PCD are multiple in nature, elucidating the underlying pathways that mediate PCD may serve to develop effective therapeutic strategies against neurodegeneration.
Experimental models have illustrated that ischemic generation of the free radical nitric oxide (NO) can be a trigger for the subsequent induction of neuronal PCD in a variety of cell types, such as cortical neurons (Brune et aI., 1999) , hippocampal neurons (Maiese et aI., 1999; Maiese and Vincent, 2000) , and mesencephalic neurons (Hunot et aI., 1996) . Cellular pathways generated by NO that result in PCD are varied, but include constitutive and inducible neuronal endonucleases (Vincent and Maiese, 1999b; Vincent et aI., 1999a) , intracellular acidification (Ito et aI., 1997; Vincent et a!., 1999b) , and cysteine proteases (Maiese and Vincent, 1999; Uehara et aI., 1999) . As a result of its close link to the molecular path ways that lead to PCD, NO functions not only as a po tential therapeutic target, but also as a valuable investi gational agent.
Neuronal PCD is believed to proceed through two dy namic, but distinct, pathways that involve DNA frag mentation and the loss of membrane asymmetry with the exposure of membrane phosphatidylserine (PS) residues (Vincent and Maiese, 1999a; Maiese and Vincent, 2000) . These processes are functionally independent determi nants of neuronal PCD. The internucleosomal cleavage of genomic DNA into fragments may be a late event during PCD and ultimately commit a cell to its death. In contrast, the redistribution of membrane PS residues can be an early event during PCD that usually precedes DNA fragmentation (Rimon et aI., 1997; Vincent and Maiese, 1999a) and may serve to "tag" injured cells for phago cytosis (Verhoven et a!., 1999) . Recent work that uses the ability to follow the progressive externalization of membrane PS residues in adherent monolayer living neu rons over time has provided evidence that neuronal PCD may also be reversible in nature (Vincent and Maiese, 1999a; Maiese and Vincent, 2000) .
Studies using neuroprotective regiments, such as the application of either trophic factors (Kiprianova et aI., 1999) or metabotropic glutamate receptor agonists (Ma iese et a!., 1999; Vincent et a!., 1999a; Maiese and Vin cent, 2000) , have further assisted in demonstrating the concept of reversible neuronal injury. Previous work has shown that the initial stages of PCD can be significantly prevented with appropriate therapeutic intervention, such as during neuronal ischemia (Schulz et aI., 1998) and free radical exposure (Brune et aI., 1999; Maiese and Vincent, 1999; Vincent et a!., 1999a) . Further support for the reversible nature of neuronal PCD has been sug gested with the agent nicotinamide, an essential precur sor of nicotinamide adenine dinucleotide. Nicotinamide was observed to be neuroprotective at least two hours after the onset of permanent focal cerebral ischemia in rats (Ayoub et aI., 1999) . Although nicotinamide appears to be an attractive therapeutic agent against neuronal injury and is membrane diffusable to directly modulate hippocampal action potentials (Wallis et aI., 1996) , the underlying mechanisms that determine this neuroprotec tion have not been elucidated.
In the current study, the authors used nicotinamide as an investigational tool to demonstrate that NO-induced neuronal PCD is not only reversible, but preventable, through the preservation of genomic DNA integrity and through the extended maintenance of cellular membrane asymmetry. The current studies illustrate that the neuro protective ability of nicotinamide is robust and novel. Nicotinamide, through its ability to regulate caspase 1 (interleukin converting enzyme, ICE) and caspase 3 (CPP32), can modulate independent components of PCD by maintaining DNA integrity and cellular membrane asymmetry. Nicotinamide also offers enhanced protec tion through the modulation of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP) and the preven tion of membrane PS exposure that can protect neurons from being "tagged" for destruction. Neurons were maintained in growth medium at 37"C in a hu midified atmosphere of 5% CO2 and 95% room air. All experi ments were performed with neurons that had been in culture for 2 weeks. Nonneuronal cells accounted for 10% to 20% of the total cell population.
MATERIALS AND METHODS

Primary hippocampal neuronal cultures
Experimental treatments
Nitric oxide administration was performed by replacing the culture media with media containing 3-morpholinosydnon imine (SIN-I) (300 fLmol/L) (Alexis Corporation, San Diego, CA, U.S.A.) or 6-(2-hydroxy-l -methyl-2-nitrosohydrazino) -N-methyl-I -hexanamine (NOC-9) (300 flmollL) (Calbio chern, San Diego, CA, U.S.A.) for 5 minutes. The authors have shown previously that SIN-I and NOC-9 are directly toxic to hippocampal neurons through a mechanism that involves the release of NO with a 5-minute application of 300 fLmollL re sulting in the death of approximately 70% to 80% of neurons over a 24-hour period (Maiese and Boccone, 1995; Vincent and Maiese, 1999b ). More than one NO generator was used as a control to demonstrate that the neurons were responding to NO rather than to other by-products of these agents. After treatment with the NO donors, the culture medium was replaced with fresh growth medium and the cultures were placed in a nor moxie, humidified incubator at 37"C with 5% CO2 for periods determined by the specific experimental paradigm. In both pre and postparadigm applications, nicotinamide exposure was continuous. 
Neuronal survival assays
Reversible assessment of phosphatidylserine residues externalization
Externalization of membrane PS residues was determined by annexin V labeling as described in previous studies (Vincent and Maiese, 1999a; Maiese and Vincent, 2000) . The growth medium was removed from culture plates, annexin V conjugate was applied in a final concentration of 3 fLg/mL and incubated at 37°C in a humidified atmosphere in the dark for 10 minutes.
Plates were then rinsed twice using fresh binding buffer. Neu detached by washing three times in dissociation buffer (10 mmollL HEPES, pH 7.5, 150 mmollL NaCI, 5 mmollL KCI, 2.8 mmollL MgCI2), which differed from binding buffer in that the calcium was replaced with magnesium. Plates could then be reexamined to confirm that the annexin V was completely re moved and returned to the incubator for a further specified period. Plates were restained using the same method. By draw ing a grid on the bottom of the culture dish, the same fields of neurons could be relocated for sequential imaging. The propor tion of stained neurons in each field was counted with 20 to 100 neurons per field and 6 to 10 fields per plate giving an n = I determination.
Assessment of ICE and CPP32-like activity
At specific times after NO exposure, caspase I (ICE) and caspase 3 (CPP32) activity were determined as previously de scribed (Maiese and Vincent, 1999 
Measurement of intracellular pH
Similar to the authors' previous work (Vincent et aI., 1999h) , To transiently modulate pH; of culture neurons, ammonium chloride (15 mmollL) in growth medium was applied to cul tures, the medium was then replaced with fresh growth medium after 5 minutes. This procedure has been shown to cause tem porary intracellular acidification without altering the extracel lular pH (Thomas, 1984) ,
Statistical analysis
For each experiment involving assessment of neuronal sur vival, neuronal PCD and caspase activity differences between groups were statistically analyzed by means of analysis of vari ance and the Student's paired t-test.
RESULTS
Nicotinamide alters neuronal survival at elevated concentrations
As compared with neuronal survival in untreated con trol cultures (86 ± 4%, mean ± SD), no significant tox icity was present in the cultures containing nicotinamide in the concentrations of 1 mmollL to 25 mmollL over a 24-hour period (Fig. 1) . Concentrations of nicotinamide greater than 50 mmollL were toxic and yielded a signifi cant decrease in neuronal survival.
Nicotinamide increases neuronal survival during NO toxicity
Pretreatment with nicotinamide enhances neuronal survival during nitric oxide toxicity. To examine the ability of nicotinamide to modulate NO toxicity, increas ing concentrations of nicotinamide (I to 25 mmol/L) were administered directly to the cultures I hour before exposure of the NO donors NOC-9 (300 /-LmoI/L) or SIN-l (300 /-LmoI/L), and neuronal survival was assessed 24 hours later. As shown in Fig. 2A tected neurons against NO toxicity. The maximum neuronal survival was seen in cultures containing a con centration of nicotinamide of 12.5 mmollL (71 ± 4%).
Posttreatment with nicotinamide increases neuro nal survival during nitric oxide toxicity. To examine the neuroprotective ability of nicotinamide in posttreat-ment paradigms, neuronal cultures were treated at 2, 4, 6, and 12 hours after NO exposure with 12.5 mm61/L of nicotinamide. As shown in Fig. 2B , posttreatment with nicotinamide at 2 hours after NO exposure significantly increased neuronal survival from 28 ± 4% (NO only) to 56 ± 5% (NO and nicotinamide). Treatment with nico tinamide at 4 hours and 6 hours after NO exposure in creased neuronal survival to 48 ± 8% and to 42 ± 7%, respectively. In contrast, treatment with nicotinamide at 12 hours after NO exposure did not significantly increase neuronal survival.
Nicotinamide prevents nitric oxide-induced pro grammed cell death. Pretreatment with nicotinamide at concentrations of 1.0 mmollL and 5.0 mmol/L did not significantly alter DNA fragmentation induced by NO (Fig. 3A ). Yet, similar to the authors' neuronal survival assays, increasing concentrations of nicotinamide (7.5 mmol/L, 10 mmol/L, 12.5 mmol/L, and 15 mmol/L) sig nificantly decreased NO-induced DNA fragmentation, and the maximum prevention of PCD induction was pre sent with a concentration of nicotinamide of 12.5 mmoll L. In a posttreatment paradigm (Fig. 3B ), application of nicotinamide after NO exposure significantly decreased DNA fragmentation from 70 ± 3% (NO only) to 33 ± 6%
(P < 0.01) at 2 hours, 41 ± 8% (P < 0.05) at 4 hours, and 44 ± 4% (P < 0.05) at 6 hours. Application of nicotin amide at 12 hours after NO exposure did not signifi cantly prevent NO-induced DNA fragmentation.
Nicotinamide prevents the externalization of mem brane phosphatidylserine residues. Because the ability to rapidly identify the onset and progression of PCD can be crucial to critically evaluate the efficacy of a thera peutic regiment, the authors developed a reversible assay using annexin V labeling to detect membrane PS over time in living neurons (Vincent and Maiese, 1999a; Maiese and Vincent, 2000) . In neurons exposed to the NO donors SIN-l (300 /-Lmol/L) or NOC-9 (300 /-Lmol/L), a progressive increase in membrane PS exposure was observed over a 24-hour period during NO toxicity (Fig.  4) . Application of nicotinamide (12.5 mmollL) 1 hour before NO exposure inhibited NO-induced externaliza tion of membrane PS residues at each time point exam ined (Fig. 4) . A slight increase in membrane PS exposure was observed in untreated control cultures from 14 ± 2% to 22 ± 6% over a 24-hour period. This induction of membrane PS exposure in control cultures might repre sent mild mechanical induction of membrane PS expo sure during the staining and washing procedures. In posttreatment paradigms, the authors further as sessed the ability of nicotinamide to prevent membrane PS exposure after NO exposure. A representative se quence of transmitted (T) and fluorescent (F) light im ages of the same microscope field for a neuron is illus trated in Fig . DNA fragmentation was assessed 24 hours after NO exposure using the TUNEL assay. In the absence and presence of NO exposure, the mean DNA fragmentation was 20 ± 4% and 71 ± 5%, respec tively. Nicotinamide significantly decreased DNA fragmentation during NO toxicity at concentrations of 5 mmol/L, 10 mmol/L, 12.5 mmollL, and 15 mmol/L when compared with cultures exposed to NO only (*P < 0.01, analYSis of variance). (B) Posttreatment with nicotinamide (12.5 mmol/L) significantly inhibits the increase in DNA fragmentation induced by NO at 2, 4, and 6 hours after NO exposure (300 j.JmollL, SIN-1, or NOC-9) (*P < 0.05, analysis of variance). In A and B, to simplify the figure, the results for the two NO donors were combined. Mean TUNEL positive neurons was determined by counting 8 randomly selected nonoverlapping fields containing 10 to 20 neurons. Each culture dish represents an n = 1 determination with each experiment replicated indepen dently 4 to 6 times using different cultures. Data for each con centration of nicotinamide represent the mean and SO.
(12.5 mmol/L) was applied 6 hours after exposure to NOC-9 (300 /-LmoIlL). A neuron is labeled for surface PS at 3 hours after NO exposure as indicated by a white arrow. After application of nicotinamide at the 6-hour period, the neuron rapidly reversed the externalization of membrane PS residues by the 7 -hour period. This neuron that reversed PS externalization remained negative for surface PS over a 24-hour period. Quantitation of surface PS after posttreatment regi ments was performed in the same manner as the pretreat ment experiments above. As shown in Fig. 6A istration of NO alone resulted in the exposure of mem brane PS residues in approximately 76% of the neuronal population over a 24-hour period and this increase was prevented by nicotinamide in each posttreatment group. This attenuation of membrane PS exposure by nicotin amide occurred within I hour of application of nicotin amide (Figs. 6B to 6D ). In addition, these posttreatment paradigms were able to reverse some of the initial expres sion of membrane PS exposure after NO administration.
Nicotinamide inhibits ICE and CPP32-like activity induced by nitric oxide exposure. The authors assessed the ability of nicotinamide to alter ICE and CPP32 ac tivity after NO exposure with SIN-I (300 /-LmollL) or NOC-9 (300 /-Lmol/L). As shown in Fig. 7 A, a significant increase in the cleavage of Ac-YV AD, a substrate for ICE, was observed in cultures after exposure to NO alone. Similarly, an increase in CPP32-like activity was detected at this time point during NO toxicity (Fig. 7B ). Pretreatment with nicotinamide (12.5 mmol/L) signifi cantly prevented NO-induced activation of ICE (0.10 ± 0.04 /-Lmollmin' g, P < 0.0 1) and CPP32 (0.1 1 ± 0.05 /-Lmollmin'g, P < 0.0 1) when compared with cultures exposed to NO alone ( Figs. 7 A and 7B) .
Nicotinamide inhibits the cleavage of P ARP during nitric oxide exposure. To further characterize the neu roprotective pathways of nicotinamide during NO induced PCD, the authors examined the cleavage of P ARP during NO and nicotinamide administration. The authors selected the time period of 12 hours post-NO exposure because this period represented a peak for CPP32 activity and allowed for significant degradation of P ARP after NO exposure (Maiese and Vincent, 1999) . Figure 8 illustrates that exposure to the NO generators SIN-l or NOC-9 significantly decreased the amount of the intact form of the P ARP protein over a 12-hour pe riod after NO exposure (lane 4). This decrease in the amount of the 116 kDa P ARP protein was attenuated in cultures by pretreatment with nicotinamide (12.5 mmoll L) (lane 5).
Nicotinamide does not prevent intracellular acidi fication-induced neuronal injury. Figure 9 illustrates a serial temporal modulation of pHj after exposure to the NO donors SIN-I (300 /-Lmol/L) or NOC-9 (300 /-Lmoll L). Exposure to NO resulted in a biphasic response for pHj Treatment with nicotinamide (12.5 mmol/L) alone did not alter neuronal pHj (data not shown). In addition, pretreatment with nicotinamide (12.5 mmoIlL), a neuro protective concentration, 1 hour before NO exposure did not significantly prevent the rapid acidification in neu ronal cultures (pH 6.98 ± 0.06) during NO exposure. To further investigate whether nicotinamide prevented acidification-induced neuronal injury, the authors used an experimental model for the induction of intracellular acidification that could replicate the changes in pHi pro duced during NO exposure (Thomas, 1984; Vincent et aI., 1999b) . As shown in Fig. 10 , application of NH4+( -) alone significantly reduced neuronal survival over a 24hour period. Administration of nicotinamide did not alter neuronal survival during intracellular acidification as compared with the untreated control group.
DISCUSSION
The cellular pathways that determine PCD are broad in nature but can be responsive to modulation. However, approaches to the prevention of neuronal injury first require an understanding of the mechanisms of PCD Neurons were repeatedly labeled with annexin V phycoerythrin at 1, 3, 5, and 7 hours after exposure to NO. The NO donors SIN-1 (300 �moIlL) and NOC-9 (300 �moIlL) were used. NOC-9 was the NO donor in the rep resentative figure. At each time-point indicated, the same field of neurons was imaged using transmitted light (T) microscopy. Corresponding fluo rescent light (F) images were ob tained using 490 nm excitation and 585 nm emission wavelengths to lo cate the annexin V-phycoerythrin la bel. The annexin V label was com pletely removed in calcium-free buffer after each time-point. Nicotinamide (NIC) (12.5 mmollL) was applied one time at the specific period indicated after NO exposure. A 6-hour post-NO treatment is illustrated. One neuron is illustrated and labeled for PS exter nalization at the 3-hour period as in dicated by the white arrow. At the 7-hour period, 1 hour after NIC appli cation, membrane PS exposure is re versed in the neuron. This neuron that reversed PS externalization re mained negative for surface PS over a 24-hour period. during neurodegeneration. In this respect, we have used nicotinamide as an investigative tool to examine the abil ity of this agent to protect or rescue neurons in culture from NO-induced PCD. We demonstrate that nicotinamide can reduce NO induced neuronal PCD and increase neuronal viability in a concentration-specific manner. Treatment with nicotin amide in a range of 7.5 to 15.0 mmollL can significantly protect neurons from NO toxicity. This concentration range is similar to other injury paradigms of neuropro tection with nicotinamide (Wallis et aI., 1996) and par allels the concentrations used in clinical studies that have demonstrated no detrimental effects on the cardiovascu lar system (Stratford et aI., 1992) . Concentrations of nic otinamide that were greater than 20 mmollL were not protective and became toxic at 50 mmol/L when present during a 24-hour incubation period in neuronal cultures. Interestingly, the neuroprotective effects of nicotinamide in animal models of cerebral ischemia were also concen tration-specific with toxicity illustrated at elevated con-centrations. Only intraperitoneal injections of nicotin amide that reached 500 mg/kg, but not greater, were able to significantly reduce focal cerebral ischemia (Ayoub et a!., \999). Although unclear at this time, there may be several reasons for a limited concentration range of nic otinamide that offers protection from injury. For ex ample, exposure to high concentrations of nicotinamide has been found to inhibit the function of rat beta-cells, decrease DNA content of adult rat islet cells, and induce cell death in fetal rat islet cells (Reddy et a!., \995). Nicotinamide also can induce the release of choline in hippocampal slices (Erb and Klein, 1998) . Although an increased release of choline may sometimes be neuro protective against ischemic injury (D' Orlando and Sandage, 1995) , high concentrations of nicotinamide can trigger excessive release of choline that may precipitate neuronal injury (Koppen et aI., 1993) .
Programmed cell death involves at least two distinct pathways that may each mediate neuronal injury. Nuclear DNA fragmentation and loss of membrane activities were determined by measuring the cleavage of sub strates, Ac-YVAD-pNA and Ac-DEVD-pNA, respectively. In A and B, neuronal cultures were exposed to the NO donors SIN-1 or NOC-9 (300 IJmol/L) for 5 minutes and caspase activity was assessed at 6 hours after NO exposure. To simplify the figure, the results for the two NO donors were combined. Control cultures were without treatment or NO exposure. Pretreatment with nico tinamide (12.5 mmol/L) 1 hour before NO exposure significantly prevented the increase in the activity of ICE (A) and CPP32 (B) induced by NO exposure. Results of ICE and CPP32 activity between the NO-exposed group and the control, NIC, and NICI NO groups were statistically different with * P < 0.001, analysis of variance. Each data point represents the mean and SD from 6 to 8 experimental preparations.
asymmetry are separate processes that can lead to neu ronal PCD (Vincent and Maiese, 1999a; Maiese and Vin cent, 2000) . Our studies with nicotinamide have indi cated a separate biologic role for DNA degradation that is distinct from the inversion of membrane PS residues. Similar in its ability to prevent neuronal injury after NO exposure, our initial work with nicotinamide prevented the induction DNA degradation after NO exposure. Pro tection against DNA degradation was concentration de pendent and most effective in the range of 7.5 mollL to 15.0 mmollL. Concentrations greater than 20.0 mmol/L were ineffective against NO-induced PCD.
The current work suggests that nicotinamide provides a unique protective ability that can maintain intact mem brane asymmetry for extended periods after neuronal in jury that is not seen with other neuroprotective regi-J Cereb Blood Flow Metab. Vol. 20, No.9, 2000 ments. Administration of nicotinamide during NO expo sure prevented and maintained the induction of membrane PS inversion over a 24-hour period. The ex ternalization of membrane PS residues can mediate cell injury independently from DNA fragmentation during PCD (Maiese and Vincent, 2000) . It is conceivable that nicotinamide maintains membrane PS asymmetry through the modulation of random "flip-flop" membrane phospholipids (Bratton et aI., 1997) . Alternatively, nic otinamide may maintain cellular energy metabolism be cause exposure of membrane PS residues on the mem brane surface is an active process facilitated by an ATP dependent membrane translocase (Verhoven et aI., 1999) . With the prolonged maintenance of membrane PS asymmetry, nicotinamide also provides an enhanced level of neuroprotection. Membrane PS externalization is believed to function as a cellular "marker" or "tag" for neurons that are to be identified for subsequent removal (Verhoven et aI., 1999; Maiese and Vincent, 2000) . The removal of neurons that have been "tagged" with membrane PS exposure may ultimately be deleterious to an organism through the elimination of neurons that may otherwise be functional and irreplaceable. Prevention of membrane PS exposure by neuroprotective strategies, such as with nicotinamide, may prevent or lessen the severity of a neuronal injury. The use of posttreatment strategies with nicotinamide illustrated that PCD appears to be reversible in nature rather than being a series of fixed, committed cellular pathways that result in neuronal injury. During the 2-, 4-, and 6-hour posttreatment regiments, nicotinamide was able to reverse an initial progression of membrane PS inversion and maintain the suppression of PS exposure over the next 24-hour period after NO exposure. These results suggest that PCD, at least along the pathway that involves membrane PS exposure, is dynamic and revers ible in nature. In addition, similar to the pretreatment regiments, the posttreatment paradigms with nicotin amide not only reverse PS exposure, but also maintain membrane asymmetry at significantly lower levels than injured untreated neurons. These results suggest that the rapid reversal and restoration of membrane asymmetry during a critical period of repair by nicotinamide may impart an additional advantage for prolonged neuronal survival.
The ability of nicotinamide to prevent genomic DNA degradation and maintain membrane PS asymmetry may be closely linked to the modulation of cysteine protease activity. Nitric oxide is thought to be one of the signal transduction systems that can elicit cysteine protease ac tivity and can directly stimulate caspase I and caspase 3-like activities (Brune et aI., 1999; Maiese and Vincent, 1999) . Caspase 1 has been linked to the modulation of membrane PS residues through cytoskeletal proteins such as fodrin (Cryns et aI., 1996) . Caspase 3 can lead to the direct degradation of DNA through the enhancement of DNase activity (Enari et aI., 1998) . Application of nicotinamide directly prevented the activation of caspase 1 and caspase 3-like activities after NO exposure, sug gesting that nicotinamide may maintain genomic DNA integrity and membrane PS asymmetry through the modulation of cysteine protease activity.
In addition to directly downregulating cysteine prote ase activity, nicotinamide also prevented the cleavage of the specific CPP32 substrate poly(ADP-ribose) polymer ase (PARP) that is required for DNA-repair (Berger, 1985) . Our work illustrates that nicotinamide prevented the degradation of PARP during NO-induced PCD. After NO exposure, nicotinamide maintained the intact form of 116kDa PARP. Without the application of nicotinamide during NO exposure, a decrease in the amount of 116 kDa PARP was evident. Proteolytic fragments of PARP, such as the 85 kDa form, were not evident suggesting subsequent PARP cleavage during NO administration similar to other ischemic injury paradigms (Taylor et aI., 1997) . In addition, because nicotinamide alone can lead to the ribosylation of PARP (Bredehorst et aI., 1980) , the FIG. 10. Nicotinamide (NIC) does not protect neurons from in tracellular acidification. Intracellular acidification was performed by the addition of ammonium ions (NH4 + (+)) and the subsequent removal of the ammonium ions (NH4+ (-)) for transient acid loading. Neuronal survival was quantitated at 24 hours after the addition of ammonium ions using a trypan blue dye exclusion assay. In the absence of ammonium ions untreated control neu ronal survival was 82 ± 6%. Intracellular acidification decreased neuronal survival from approximately 82% to 42% over a 24-hour period. Pretreatment with nicotinamide (5 mmol/L, 12.5 mmol/L, and 15.0 mmollL) 1 hour before the addition of ammonium ions did not increase neuron survival compared with NH4+ (-) only treated neurons. Mean proportion of stained neurons was calcu lated by counting 8 randomly selected nonoverlapping fields con taining 10 to 20 neurons. Each culture dish represents an n = 1 determination with each experiment replicated independently 4 to 6 times using different cultures.
absence of the 85 kDa form of P ARP is not a result of possible ribosylation of epitope binding sites. It is con ceivable that nicotinamide maintains DNA integrity through at least two possible pathways that involve PARP. First, nicotinamide may prevent PARP degrada tion and allow for DNA repair through the direct inhibi tion of CPP32 activity. Second, nicotinamide also may modulate the activity of P ARP to prevent excessive en ergy depletion that may be detrimental. Excessive acti vation of PARP has been shown to deplete NAD and A TP and subsequently lead to cell death through energy depletion (Endres et aI., 1997) . Nicotinamide concentra tions of at least I mmollL have been shown to provide sufficient stores of NAD during PARP activation (Smets et aI., 1990) . Although nicotinamide may offer protection against PCD through a series of cellular pathways, one attractive mechanism to enhance neuronal survival is through the regulation of intracellular acidification. Nitric oxide can lead to a rapid and robust intracellular acidification that directly enhances neuronal endonuclease activity and leads to subsequent PCD (Vincent and Maiese, I 999b; Vincent et aI., 1999b) . However, our work demonstrated that nicotinamide does not directly prevent the induction of intracellular acidification by NO and does not prevent neuronal injury during intracellular acidification para digms. These results suggest that nicotinamide maintains genomic DNA integrity through mechanisms that are in dependent of intracellular pH.
In summary, we have used the agent nicotinamide to illustrate that neuronal PCD can be a reversible process during its initial stages and is composed of two indepen dent components. The first component is the degradation of genomic DNA which may impact on immediate neu ronal survival and is dependent upon cysteine protease activity. The second component in NO-induced PCD in volves the loss of membrane asymmetry and the subse quent extemalization of PS residues. The loss of mem brane asymmetry may subsequently "tag" neurons for subsequent destruction and also may be linked to en hanced cysteine protease activity during NO exposure. Nicotinamide is a unique and attractive neuroprotectant in its ability to maintain prolonged genomic DNA integ rity and membrane PS asymmetry during pretreatment and posttreatment regiments. The current work initiates the development of more efficacious therapeutic strate gies against neurodegeneration that may not only reverse the course of PCD, but also prevent the "tagging" of neurons for subsequent destruction.
